BiophysicsbioRxiv
A blueprint for high affinity SARS-CoV-2 Mpro inhibitors from activity-based compound library screening guided by analysis of protein dynamics
J. Gossen, S. Albani, A. Hanke…·G. Rossetti
The paper identifies a blueprint for high affinity SARS-CoV-2 Mpro inhibitors by analyzing protein dynamics and redefining druggability through virtual screening and pharmacophore modeling.
DOI 10.1021/acsptsci.0c00215